Good day and thank you for joining us. I have a few questions that I will put to you in quick succession, after which you can respond.
Earlier, you stated that several drugs were administered to people who were not members of the group targeted by these studies. I was wondering how many people taking this drug fell into this category and how serious the problem actually was?
You also suggested that an independent evaluation bureau be set up. What type of funding should this bureau receive and what advantage would this present over the system currently in place?
Thank you.